J.H. Lee

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Brain‐derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood‐derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt‐dependent signaling pathways

Jung Yeon Lim, Sang‐In Park, Ji Hyeon Oh et al. · Journal of Neuroscience Research · 2008 · 158 citations

Life Sciences, Cell Biology, Developmental Biology +17

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

S.T. Kim, Kimberly C. Banks, Eirini Pectasides et al. · Annals of Oncology · 2018 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical outcomes of endoscopic submucosal dissection (ESD) for treating early gastric cancer: Comparison with endoscopic mucosal resection after circumferential precutting (EMR-P)

Byung‐Hoon Min, J.H. Lee, J.J. Kim et al. · Digestive and Liver Disease · 2008 · 89 citations

Medicine, Oncology, Surgery +14

Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma

J.M. Kim, Choon Hyuck David Kwon, Jae‐Won Joh et al. · Transplantation Proceedings · 2014 · 47 citations

Medicine, Oncology, Surgery +13